ACTA1 and acute myeloid leukemia: In the present study, the DIM treatment restored the expression of E-cadherin and ZO-1 but reduced the protein levels of vimentin, N-cadherin, α-SMA, Smad2/3, and Snail in TGF-β1-treated AML-12 cells.